Commission Regulation (EU) No 823/2012 of 14 September 2012 derogating from Implementing Regulation (EU) No 540/2011 as regards the expiry dates of the approval of the active substances 2,4-DB, benzoic acid, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, cyfluthrin, deltamethrin, dimethenamid-P, ethofumesate, ethoxysulfuron, fenamidone, flazasulfuron, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mecoprop, mecoprop-P, mesosulfuron, mesotrione, oxadiargyl, oxasulfuron, pendimethalin, picoxystrobin, propiconazole, propineb, propoxycarbazone, propyzamide, pyraclostrobin, silthiofam, trifloxystrobin, warfarin and zoxamide Text with EEA relevance
Amendments and corrections
May 26, 2014 Modified by 32014R0460 - detail
March 19, 2014 Modified by 32014R0186 - detail
October 5, 2012 Entry into force - Date pub. +20 See Art 2
Consolidated texts
May 26, 2014 Modified by
32012R0823
02012R0823-20140319
32014R0186
32014R0460
02012R0823-20140526
March 19, 2014 Modified by
32012R0823
32014R0186
02012R0823-20140319
September 15, 2012 Date of publication 32012R0823